Miracor Medical SA
Medical Equipment ManufacturingView the employees at
Miracor Medical SA-
Dana Litman Quality and Design Assurance at Miracor Medical Systems SA
-
Top 5%
Gill Glennon Clinical Specialist/CRA at Miracor Medical SA-
Top 5%
Oliver Kohr CTO at miracor medical systems GmbH-
Zurich, Switzerland
-
Rising Star
Dieter Govaerts Clinical Affairs Manager bij Miracor Medical SA-
Landen, Flemish Region, Belgium
-
Rising Star
Kimberlie (Heath) O'Connell VP Regulatory/Quality Affairs & US Operations at Miracor Medical S.A.-
Top 10%
Overview
Miracor Medical SA is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. Miracor develops and studies the PiCSO® (Pressure-controlled intermittent Coronary Sinus Occlusion) Impulse System, which is used as an adjunctive technique during the primary PCI procedure for acute myocardial infarction patients. PiCSO therapy seeks to improve coronary microvascular function to reduce infarct size and salvage myocardium, thereby improving outcomes of ST-elevation myocardial infarction (STEMI) patients. Recent Clinical Studies have successfully demonstrated the safety and positive effects of PiCSO on coronary microvascular function and infarct size reduction in STEMi patients. The company is conducting further clinical trials in Europe and plans to initiate a US IDE randomized controlled trial in 2023. Miracor has won several innovation awards and completed financing rounds raising venture capital and public funding. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
-